2019
DOI: 10.1016/j.jconrel.2019.04.016
|View full text |Cite
|
Sign up to set email alerts
|

Catechin solubilization by spontaneous hydrogen bonding with poly(ethylene glycol) for dry eye therapeutics

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
17
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 37 publications
(17 citation statements)
references
References 43 publications
0
17
0
Order By: Relevance
“…Finally, it is also true that in vivo models are much more complex. For many of the compounds [72,73,76,77,79,[91][92][93] and extracts [46,87,88,[94][95][96][97] mentioned in the bibliography, the anti-inflammatory activity has also been proven in vivo. For EGCG [98] and Daidzin [73], the in vivo antioxidant effect has also been studied.…”
Section: Discussionmentioning
confidence: 99%
“…Finally, it is also true that in vivo models are much more complex. For many of the compounds [72,73,76,77,79,[91][92][93] and extracts [46,87,88,[94][95][96][97] mentioned in the bibliography, the anti-inflammatory activity has also been proven in vivo. For EGCG [98] and Daidzin [73], the in vivo antioxidant effect has also been studied.…”
Section: Discussionmentioning
confidence: 99%
“…The effectiveness of the formulation was further confirmed by tissue immunostaining. Reduced expression of different inflammatory markers (VCAM-1, IL-6, ICAM-1, and TNF-α) was observed in tissues from diseased animals treated with the PEG/catechin complex, indicating an anti-inflammatory effect [103].…”
Section: Catechinmentioning
confidence: 95%
“…This formulation strategy exploits the formation of hydrogen between the ether oxygen present in the PEG polymeric chain and the catechol group that is part of the structure of catechin. Catechin formulated in this way was tested as a potential treatment for DED in NOD.B10-H2b mice exposed to desiccating stress to develop experimental DED [103]. The complex PEG/catechin topically administered was able to prevent conjunctival goblet cells from deterioration, as demonstrated by the number of goblet cells recovered in DED-treated animals compared to untreated control animals.…”
Section: Catechinmentioning
confidence: 99%
“…Because hydrogen can selectively neutralize cytotoxic reactive oxygen species and reduce harmful inflammation, local instillation, or IVS has been used to treat local injuries and chronic inflammation 92 . As an ocular antiinflammatory drug, hydrogen can also significantly reduce the circulating levels of a variety of proinflammatory cytokines (e.g., IL-1β, IL-6, ligand 2 (CCL2), and tumor necrosis factor-α) and ameliorate the accumulation of activated microglia 93 .…”
Section: Treatment Of Eye Diseasesmentioning
confidence: 99%